SOVAPE Disbands: Impact on the E-Cigarette Community

Oct.10.2024
SOVAPE Disbands: Impact on the E-Cigarette Community
French e-cigarette organization SOVAPE announced its dissolution after facing allegations of ties to the tobacco industry.

According to a recent report by Vaping 360, the French e-cigarette organization SOVAPE announced this week that it will be dissolving.


It is reported that SOVAPE has been active in the e-cigarette industry since 2016, gaining recognition for hosting three editions of the French e-cigarette summit from 2016 to 2019. The organization is also a co-founder of the European Tobacco Harm Reduction Advocates (ETHRA) alliance.


Since 2019, SOVAPE has commissioned the well-known market research company BVA to survey the French public's opinion on e-cigarettes and nicotine. However, this year (2024), BVA informed SOVAPE that due to a contract with a health industry client prohibiting BVA from collaborating with organizations associated with nicotine, BVA will no longer be involved.


The sudden cancellation of this survey, coupled with recent news reports accusing SOVAPE and other consumer organizations of being linked to the tobacco industry, has led to attacks on scientists and health professionals supporting SOVAPE. On October 6, SOVAPE announced on its official website that "the review, threats, lies, defamation, as well as the spread of fake news and denial of scientific data have created an atmosphere that makes it impossible to sustain this mission." The association announced its dissolution.


SOVAPE has decided to donate its remaining funds to the Pasteur Institute, as well as other e-cigarette organizations AIDUCE and La Vape du Cœur. In addition, SOVAPE has covered the costs to ensure its website remains available for the next 10 years, and has preserved the relevant videos of e-cigarette summit on its YouTube channel.


We regret that we can no longer continue the dialogue to promote methods that reduce the risk of disease prevention and premature death. We do not regret trying, but we must acknowledge that we can no longer continue this crucial fight for us. However, our efforts have already made a contribution to saving lives!


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Australia forms National Disruption Group to combat illicit tobacco and converging crime threats
Australia forms National Disruption Group to combat illicit tobacco and converging crime threats
Australia establishes new national task force to combat illegal tobacco market, led by Interior Minister Tony Burke.
Oct.20 by 2FIRSTS.ai
Illegal Vape Sellers in the Netherlands Could Be Fined Up to €4,040
Illegal Vape Sellers in the Netherlands Could Be Fined Up to €4,040
The outgoing Dutch government plans to raise fines for illegal sales of vapes and cigarettes, with first-time offenders facing a €2,040 penalty. The new fines, up to €4,040 for large companies, are expected to take effect on July 1, 2026, pending parliamentary approval.
Nov.10 by 2FIRSTS.ai
Thai Police Seize 48,000 Illegal E-Cigarettes Worth About $630,000
Thai Police Seize 48,000 Illegal E-Cigarettes Worth About $630,000
Acting on directives from senior government and police officials, Thai authorities seized 48,301 e-cigarettes and related products in central Thailand, valued at about 20 million baht (approximately US$630,000), as part of a crackdown on illegal vaping.
Oct.15 by 2FIRSTS.ai
ceshi
ceshi
Nov.04
Tuscaloosa, Alabama, plans to impose an e-cigarette tax before a state law takes effect in October
Tuscaloosa, Alabama, plans to impose an e-cigarette tax before a state law takes effect in October
The Tuscaloosa, Alabama, City Council is considering imposing a local tax on e-cigarette products to meet a state bill deadline. Alabama Act 2025-377, signed into law in May, plans to impose a $0.10 per milliliter state excise tax on e-cigarette products starting in October.
Sep.25 by 2FIRSTS.ai
Indonesian Police to Crack Down on Etomidate-Laced Vapes
Indonesian Police to Crack Down on Etomidate-Laced Vapes
Indonesia’s National Police Criminal Investigation Department (Bareskrim Polri) will continue to take enforcement action against users and distributors of etomidate-laced vape liquids, even though the substance is not yet classified as a narcotic. Brigadier General Eko Hadi Santoso, Director of Narcotics Crimes, said etomidate is an anaesthetic drug regulated under Health Law No. 17 of 2023, but has not been listed as a narcotic or psychotropic substance.
Oct.23 by 2FIRSTS.ai